Information Provided By:
Fly News Breaks for March 21, 2018
NVS, MNTA, AMPH
Mar 21, 2018 | 14:17 EDT
Wells Fargo analyst David Maris called the news of Massachusetts' District Court entering a final judgement in favor of Amphastar (AMPH) in the patent lawsuit regarding Lovenox brought by Momenta (MNTA) and Novartis' (NVS) Sandoz division a "major positive" that again demonstrates Amphastar's ability to face down larger, better-funded companies and get difficult products to market. He maintains an Outperform rating on Amphastar shares.
News For AMPH;MNTA;NVS From the Last 2 Days
There are no results for your query AMPH;MNTA;NVS